Teladoc Health, Inc. (NYSE:TDOC) Insider Carlos Nueno Sells 3,958 Shares

Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) insider Carlos Nueno sold 3,958 shares of the stock in a transaction that occurred on Monday, June 2nd. The shares were sold at an average price of $6.86, for a total transaction of $27,151.88. Following the completion of the transaction, the insider now owns 17,645 shares in the company, valued at $121,044.70. This represents a 18.32% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Teladoc Health Price Performance

Shares of NYSE:TDOC traded down $0.20 during midday trading on Thursday, hitting $6.93. 5,451,781 shares of the stock were exchanged, compared to its average volume of 6,260,843. The stock has a market cap of $1.21 billion, a P/E ratio of -1.20 and a beta of 1.82. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. Teladoc Health, Inc. has a twelve month low of $6.35 and a twelve month high of $15.21. The company has a 50 day moving average price of $7.18 and a 200-day moving average price of $9.16.

Analyst Upgrades and Downgrades

TDOC has been the topic of a number of analyst reports. Piper Sandler lowered their price objective on shares of Teladoc Health from $13.00 to $12.00 and set an "overweight" rating on the stock in a research report on Thursday, February 27th. Needham & Company LLC reissued a "hold" rating on shares of Teladoc Health in a report on Thursday, May 1st. Bank of America reduced their target price on Teladoc Health from $8.00 to $7.00 and set a "neutral" rating for the company in a report on Wednesday, May 28th. Jefferies Financial Group reduced their target price on Teladoc Health from $10.00 to $8.00 and set a "hold" rating for the company in a report on Monday, April 21st. Finally, Citigroup reduced their target price on Teladoc Health from $11.00 to $8.75 and set a "neutral" rating for the company in a report on Friday, April 25th. Twelve investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus target price of $9.60.

Institutional Trading of Teladoc Health

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in TDOC. Golden State Wealth Management LLC increased its position in Teladoc Health by 102.6% during the 1st quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider's stock worth $27,000 after purchasing an additional 1,690 shares in the last quarter. National Bank of Canada FI lifted its position in Teladoc Health by 79.4% during the 1st quarter. National Bank of Canada FI now owns 3,571 shares of the health services provider's stock worth $28,000 after acquiring an additional 1,581 shares in the last quarter. Whipplewood Advisors LLC acquired a new position in Teladoc Health during the 4th quarter worth approximately $29,000. Lindbrook Capital LLC lifted its position in Teladoc Health by 78.9% during the 4th quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider's stock worth $33,000 after acquiring an additional 1,612 shares in the last quarter. Finally, SVB Wealth LLC acquired a new position in Teladoc Health during the 1st quarter worth approximately $37,000. Hedge funds and other institutional investors own 76.82% of the company's stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.